Screener
Kyverna Therapeutics, Inc. KYTX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219397
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 241,726 | 282,953 |
| Restricted cash | 551 | 551 |
| Property and equipment, net | 1,343 | 1,546 |
| Operating lease right-of-use assets | 8,192 | 3,568 |
| Finance lease right-of-use assets | 198 | 305 |
| Other non-current assets | 5,014 | 4,903 |
| Total assets | $257,024 | $293,826 |
| Liabilities and stockholders’ equity |
Item 1. Financial Statements (unaudited)
FAQ
- What is Kyverna Therapeutics, Inc.'s operating lease ROU assets?
- Kyverna Therapeutics, Inc. (KYTX) reported operating lease ROU assets of $8.19M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Kyverna Therapeutics, Inc.'s operating lease ROU assets increased by 42.1% year-over-year, from $5.76M to $8.19M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s operating lease ROU assets?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s operating lease ROU assets has grown at a -25.9% compound annual growth rate (CAGR), from $6.49M to $3.57M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Kyverna Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude